• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌的病理生物学研究进展

[Advances in pathobiological research on lung carcinoma].

作者信息

Noguchi M

机构信息

Dept. of Pathology, National Cancer Center Research Institute.

出版信息

Gan To Kagaku Ryoho. 1994 Nov;21(15):2549-54.

PMID:7979412
Abstract

Histological examination revealed that many peripheral type papillary adenocarcinomas appear to develop from atypical adenomatous hyperplasia (AAH), which can be called adenoma or in situ adenocarcinoma, and progress stepwise. Molecular-biologically, loss of heterozygosities of 3, 11 and 17 chromosomes, point mutation of ras oncogene and p53 anti-oncogene, amplification of myc oncogene, and overexpression of erbB2 oncogene are related to lung cancer development. Especially, ras and p53 gene abnormalities are closely associated with poor prognosis of lung adenocarcinoma. Future molecular-biological examinations should focus on AAH and/or early stage adenocarcinoma of the lung, in order to clarify the gene abnormality at the early stage of lung carcinogenesis.

摘要

组织学检查显示,许多外周型乳头状腺癌似乎由非典型腺瘤样增生(AAH)发展而来,AAH可称为腺瘤或原位腺癌,并呈逐步进展。从分子生物学角度来看,3号、11号和17号染色体的杂合性缺失、ras癌基因和p53抑癌基因的点突变、myc癌基因的扩增以及erbB2癌基因的过表达均与肺癌的发生发展相关。尤其是,ras和p53基因异常与肺腺癌的不良预后密切相关。未来的分子生物学检查应聚焦于肺的AAH和/或早期腺癌,以阐明肺癌发生早期的基因异常情况。

相似文献

1
[Advances in pathobiological research on lung carcinoma].肺癌的病理生物学研究进展
Gan To Kagaku Ryoho. 1994 Nov;21(15):2549-54.
2
K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.人肺非典型肺泡增生中的K-ras癌基因激活
Cancer Res. 1996 May 1;56(9):2224-8.
3
Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.肺非典型腺瘤样增生中3号、9号和17号染色体短臂的增殖活性、p53表达及杂合性缺失
Hiroshima J Med Sci. 1998 Mar;47(1):17-25.
4
[Molecular diagnosis of lung carcinoma].[肺癌的分子诊断]
Rinsho Byori. 1994 Apr;42(4):355-8.
5
A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.一部分肺腺癌和非典型腺瘤样增生相关病灶在基因分型上有关联:一项表皮生长因子受体(EGFR)、人表皮生长因子受体2(HER2)及K-鼠肉瘤病毒癌基因同源物(K-ras)突变分析。
Am J Clin Pathol. 2008 Feb;129(2):202-10. doi: 10.1309/THU13F3JRJVWLM30.
6
[Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].原发性肺癌的临床病理研究——p53抑癌基因和bcl-2癌基因的免疫组化表达与预后的关系
Rinsho Byori. 1996 Jan;44(1):32-41.
7
Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.真核生物起始因子4E在人外周肺非典型腺瘤样增生及腺癌中的表达
Clin Cancer Res. 2002 Oct;8(10):3046-53.
8
Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.包括p53和k-ras改变在内的分子事件在人结肠直肠腺瘤细胞系向腺癌体外进展过程中的作用。
Oncogene. 1993 Nov;8(11):3063-72.
9
Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung.非典型腺瘤样增生伴肺腺癌中9号染色体长臂和16号染色体短臂杂合性缺失
Am J Pathol. 2001 Nov;159(5):1941-8. doi: 10.1016/S0002-9440(10)63041-6.
10
Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.发生于良性肺组织和癌性肺组织中的非典型腺瘤样增生的分子改变。
Diagn Mol Pathol. 2007 Jun;16(2):87-90. doi: 10.1097/PDM.0b013e318030afde.